These results directly demonstrate the ability of the CD8+ cells that are derived from mice xenografted with KO#7 cells to kill the BBC2 KO#7 cells, and CD4+ T cells can enhance this tumor clearance activity. This evidence concerns the gene CD8A and neoplasm.